PROPHYLACTIC EFFECT OF NEUROLEPTICS IN SYMPTOM-FREE SCHIZOPHRENICS

被引：29

作者：

NISHIKAWA, T ^{[1
]}

TSUDA, A ^{[1
]}

TANAKA, M ^{[1
]}

KOGA, I ^{[1
]}

UCHIDA, Y ^{[1
]}

机构：

[1] SEIWAKAI NISHIKAWA HOSP,HAMADA 697,JAPAN

来源：

PSYCHOPHARMACOLOGY | 1982年 / 77卷 / 04期

关键词：

D O I：

10.1007/BF00432759

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：301 / 304

页数：4

共 22 条

[1] A STUDY OF PHENOTHIAZINES WITH MALE AND FEMALE CHRONICALLY ILL SCHIZOPHRENIC-PATIENTS [J].

ADELSON, D ;

EPSTEIN, LJ .

JOURNAL OF NERVOUS AND MENTAL DISEASE, 1962, 134 (06) :543-&

[2] HIGH-DOSE DIAZEPAM IN SCHIZOPHRENIA [J].

BECKMANN, H ;

HAAS, S .

PSYCHOPHARMACOLOGY, 1980, 71 (01) :79-82

[3] BEHAVIORAL-EFFECTS OF INTERRUPTING AND RESUMING TRANQUILIZING MEDICATION AMONG SCHIZOPHRENICS [J].

BLACKBURN, HL ;

ALLEN, JL .

JOURNAL OF NERVOUS AND MENTAL DISEASE, 1961, 133 (04) :303-308

[4]

CASEY JF, 1960, ARCH GEN PSYCHIAT, V2, P210

[5] CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIA - BEHAVIORAL DOSE-RESPONSE RELATIONSHIPS [J].

CLARK, ML ;

RAMSEY, HR ;

RAGLAND, RE ;

RAHHAL, DK ;

SERAFETI.EA ;

COSTILOE, JP .

PSYCHOPHARMACOLOGIA, 1970, 18 (03) :260-&

[6] CHLORPROMAZINE IN CHRONIC-SCHIZOPHRENIC WOMEN .1. EXPERIMENTAL-DESIGN AND EFFECTS AT MAXIMUM POINT OF TREATMENT [J].

CLARK, ML ;

RAY, TS ;

PAREDES, A ;

COSTILOE, JP ;

CHAPPELL, JS ;

HAGANS, JA ;

WOLF, S .

PSYCHOPHARMACOLOGIA, 1961, 2 (02) :107-136

[7]

DAVIS JM, 1975, AM J PSYCHIAT, V132, P1237

[8]

ENGELHARDT DM, 1967, ARCH GEN PSYCHIAT, V16, P98

[9] TERMINATION OF CHLORPROMAZINE WITH SCHIZOPHRENIC-PATIENTS [J].

GOOD, WW ;

STERLING, M ;

HOLTZMAN, WH .

AMERICAN JOURNAL OF PSYCHIATRY, 1958, 115 (05) :443-448

[10]

HARTMANN E, 1976, PSYCHOPHARMACOLOGY, V49, P1

← 1 2 3 →